Breaking News

inVentiv Names Communications Officer

May 21, 2013

Rubin brings decades of communications experience

Sydney Rubin has been appointed chief communications officer at inVentiv Health. Ms. Rubin will oversee corporate reputation, internal communications, media relations and public affairs, and reports to inVentiv’s chief executive officer, Paul Meister.
Ms. Rubin has managed public relations programs for a broad range of corporate and institutional clients in the pharmaceutical and healthcare, consumer products, technology and financial services sectors. Previously, she provided senior counsel in corporate reputation, content development, crisis communications, executive training and public affairs at Chandler Chicco Companies, part of inVentiv Health Inc. She joined Chandler Chicco with the purchase of Ignition Strategic Communications in 2005, a public relations and public affairs firm she founded.

"Sydney brings decades of communications experience to inVentiv Health, and a clear understanding of the role that consistent, integrated and compelling communications plays in building a high-value organization with a world-class reputation," said Mr. Meister.  "She will help raise awareness of inVentiv and our unique combination of sophisticated services for clients in the life sciences industry."
blog comments powered by Disqus
  • Quality Risk Management

    Quality Risk Management

    Cheryl Abernathy and Bryan Sasbon, Quality Assurance Operations Manager, Ropack Pharma Solutions; QA Director & Regulatory Affairs, Ropack Pharma Solutions||September 8, 2016
    Embracing the process as a means to a strong quality culture

  • Staying Ahead in the Small Molecule Space

    Staying Ahead in the Small Molecule Space

    Dr. Matthew Moorcroft, VP Global Marketing, Cambrex||September 8, 2016
    Understand what is happening in the market and react accordingly

  • FDA & Drug Development

    FDA & Drug Development

    Rachelle Du2019Souza, Regulatory Heights Inc.||September 8, 2016
    You must perform the necessary due diligence to stay on top of regulatory developments